Barrington Research Forecasts Strong Price Appreciation for Option Care Health (NASDAQ:OPCH) Stock

Option Care Health (NASDAQ:OPCH - Free Report) had its price objective boosted by Barrington Research from $33.00 to $38.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an outperform rating on the stock.

OPCH has been the topic of several other reports. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective for the company. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $38.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $32.88.

Remove Ads

Option Care Health Stock Performance

NASDAQ:OPCH traded up $0.46 on Thursday, hitting $33.96. The company's stock had a trading volume of 1,699,328 shares, compared to its average volume of 1,584,820. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a fifty day moving average of $28.70 and a two-hundred day moving average of $28.06. Option Care Health has a one year low of $21.39 and a one year high of $34.54. The firm has a market capitalization of $5.78 billion, a P/E ratio of 28.54, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently made changes to their positions in OPCH. Mackenzie Financial Corp raised its stake in Option Care Health by 1.1% during the 4th quarter. Mackenzie Financial Corp now owns 49,579 shares of the company's stock valued at $1,150,000 after buying an additional 556 shares during the last quarter. Peak Retirement Planning Inc. bought a new stake in Option Care Health in the 4th quarter valued at $1,026,000. Public Employees Retirement System of Ohio lifted its position in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares in the last quarter. PharVision Advisers LLC purchased a new position in shares of Option Care Health in the fourth quarter valued at $251,000. Finally, Voloridge Investment Management LLC purchased a new stake in shares of Option Care Health during the 4th quarter valued at about $27,428,000. Institutional investors own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.